Clinical Trials Directory

Trials / Completed

CompletedNCT02186990

Comparison of Etomidate, Propofol and Etomidate-propofol Combination in Terms of Effects on Haemodynamic Response to Intubation

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Ordu University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effect of propofol, etomidate and propofol-etomidate combination on hemodynamic responses during laryngoscopy and tracheal intubation and assess the adverse effect related to this drugs.

Conditions

Interventions

TypeNameDescription
DRUGpropofol2,5 mg/kg
DRUGetomidate0,3 mg/kg
DRUGetomidate-propofol0,15 mg/kg etomidate + 1,25 mg/kg propofol

Timeline

Start date
2014-05-01
Primary completion
2014-08-01
First posted
2014-07-10
Last updated
2014-08-13

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02186990. Inclusion in this directory is not an endorsement.

Comparison of Etomidate, Propofol and Etomidate-propofol Combination in Terms of Effects on Haemodynamic Response to Int (NCT02186990) · Clinical Trials Directory